• Therapy areas
  • Science & technology
  • Partnering
  • Sustainable business
  • Careers
  • About us
  • Our products
  • Investors
  • News & media
  • Healthcare professionals
  • Contact us

Latest news

{{'2026-11-16T22:00:00Z' | dateFormatFilter}}

Novo presents preclinical and human data suggesting a role for amylin and calcitonin receptor activation in preserving bone during weight loss at ObesityWeek®

Read more

{{'2026-11-16T15:00:00Z' | dateFormatFilter}}

Wegovy® resulted in a BMI reduction of 10% or more in almost 80% of children with obesity aged 6 to under 12, compared to 0% with placebo in STEP Young trial, published in The New England Journal of Medicine

Read more

{{'2026-11-15T13:00:00Z' | dateFormatFilter}}

Novo's CagriSema was associated with 25% mean weight loss among early responders in a post hoc analysis of REDEFINE 1 presented at ObesityWeek® 2026

Read more

News archive

Photo of Novo Nordisk CEO Mike Doustdar standing in front of a screen

Image of woman smiling

Photo of Novo Way logo

Stay informed

Stay informed

Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.

Please fill in the fields below to receive our news

E-mail address

Email is required Invalid email address
hCAPTCHA verification required
Unsubscribe
Anette W. Bruun, Biopharm, Måløv, Denmark

NOVO HQ

Novo Nordisk A/S
Novo Alle 1
2880 Bagsværd
Denmark
+45-4444-8888
CVR-no. 24256790

 

Our medicines are for the approved indication for which they are authorised in the local country or region. For more information, please visit our product page

Helpful links

  • Contact us about a product issue or side effect
  • Supplier help
  • Product list
  • Contact us
  • Our Purpose - Code of conduct
  • ESG reporting
  • Novo Nordisk Foundation

Follow us

  • Social media community guidelines
  • LinkedIn
  • YouTube
  • Facebook
  • X (Twitter)
  • Instagram
  • TikTok

Find your local office

Select location
© 2026 Novo Nordisk A/S
Data Privacy
Cookie policy
Cookie settings